Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hasanreisoglu M et al. - Intravitreal bevacizumab is beneficial for the treatment of anterior segment neovascularization and NVG when used as an adjunct, making the administration of additional treatment for the underlying cause possible. Bevacizumab should be instituted promptly after diagnosis, before irreversible anatomic and functional damage occurs.

   

Related Articles

Glaucoma and dry eye data from Germany
Ophthalmology Times Europe, 10/27/09    Relevance Score: 93%

Understanding the Importance of IOP Variables in Glaucoma
Survey of Ophthalmology, 10/23/09    Relevance Score: 92%

Characteristics of respondents with glaucoma and dry eye in a national panel survey
Clinical Ophthalmology, 11/13/09    Relevance Score: 91%

Gene-directed therapy in glaucoma may have future clinical applications
Ophthalmology Times Europe, 10/22/09    Relevance Score: 91%

Sequential Glaucoma Implants in Refractory Glaucoma
American Journal of Ophthalmology, 10/20/09    Relevance Score: 91%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address